HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Borradaile, N. M. Articles by Huff, M. W. Search for Related Content PubMed PubMed Citation Articles by Borradaile, N. M. Articles by Huff, M. W. Social Bookmarking                      What's this?

Journal of Lipid Research, Vol. 43, 1544-1554, September 2002
Copyright © 2002 by Lipid Research, Inc.

Inhibition of hepatocyte apoB secretion by naringenin

Nica M. Borradaile^*, Linda E. de Dreu^*, P. Hugh R. Barrett and Murray W. Huff^1,*

^* Departments of Medicine and Biochemistry and the John P. Robarts Research Institute, University of Western Ontario, London, Ontario, Canada
Department of Medicine, University of Western Australia and the Western Australia Institute for Medical Research, Perth, Australia

¹ To whom correspondence should be addressed. e-mail: mhuff{at}uwo.ca

The grapefruit flavonoid, naringenin, is hypocholesterolemic in vivo, and inhibits basal apolipoprotein B (apoB) secretion and the expression and activities of both ACAT and microsomal triglyceride transfer protein (MTP) in human hepatoma cells (HepG2). In this report, we examined the effects of naringenin on apoB kinetics in oleate-stimulated HepG2 cells and determined the contribution of microsomal lumen cholesteryl ester (CE) availability to apoB secretion. Pulse-chase studies of apoB secretion and intracellular degradation were analyzed by multicompartmental modeling. The model for apoB metabolism in HepG2 cells includes an intracellular compartment from which apoB can be either secreted or degraded by both rapid and slow pathways. In the presence of 0.1 mM oleic acid, naringenin (200 µM) reduced the secretion of newly synthesized apoB by 52%, due to a 56% reduction in the rate constant for secretion. Intracellular degradation was significantly increased due to a selective increase in rapid degradation, while slow degradation was unaffected. Incubation with either N-acetyl-leucinyl-leucinyl-norleucinal (ALLN) or lactacystin showed that degradation via the rapid pathway was largely proteasomal. Although these changes in apoB metabolism were accompanied by significant reductions in CE synthesis and mass, subcellular fractionation experiments comparing naringenin to specific ACAT and HMG-CoA reductase inhibitors revealed that reduced accumulation of newly synthesized CE in the microsomal lumen is not consistently associated with reduced apoB secretion. However, naringenin, unlike the ACAT and HMG-CoA reductase inhibitors, significantly reduced lumenal TG accumulation.

We conclude that naringenin inhibits apoB secretion in oleate-stimulated HepG2 cells and selectively increases intracellular degradation via a largely proteasomal, rapid kinetic pathway. Although naringenin inhibits ACAT, CE availability in the endoplasmic reticulum (ER) lumen does not appear to regulate apoB secretion in HepG2 cells. Rather, inhibition of TG accumulation in the ER lumen via inhibition of MTP is the primary mechanism blocking apoB secretion.

Abbreviations: ALLN, N-acetyl-leucinyl-leucinyl-norleucinal; apo, apolipoprotein; apoB-Lp, apoB-containing lipoprotein; CE, cholesteryl ester; DGAT, diacylglycerol acyltransferase; ER, endoplasmic reticulum; LPDS, lipoprotein deficient serum; MTP, microsomal triglyceride transfer protein; PDI, protein disulfide isomerase; PL, phospholipid

Supplementary key words citrus flavonoid • ACAT • oleate • endoplasmic reticulum lumen • multicompartmental modeling • kinetics • degradation • triglycerides

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				E. E. Mulvihill, E. M. Allister, B. G. Sutherland, D. E. Telford, C. G. Sawyez, J. Y. Edwards, J. M. Markle, R. A. Hegele, and M. W. Huff Naringenin Prevents Dyslipidemia, Apolipoprotein B Overproduction, and Hyperinsulinemia in LDL Receptor-Null Mice With Diet-Induced Insulin Resistance Diabetes, October 1, 2009; 58(10): 2198 - 2210. [Abstract] [Full Text] [PDF]

				E. M. Allister, E. E. Mulvihill, P. H. R. Barrett, J. Y. Edwards, L. P. Carter, and M. W. Huff Inhibition of apoB secretion from HepG2 cells by insulin is amplified by naringenin, independent of the insulin receptor J. Lipid Res., October 1, 2008; 49(10): 2218 - 2229. [Abstract] [Full Text] [PDF]

				B. Morin, L. A. Nichols, K. M. Zalasky, J. W. Davis, J. A. Manthey, and L. J. Holland The Citrus Flavonoids Hesperetin and Nobiletin Differentially Regulate Low Density Lipoprotein Receptor Gene Transcription in HepG2 Liver Cells J. Nutr., July 1, 2008; 138(7): 1274 - 1281. [Abstract] [Full Text] [PDF]

				T. L. Zern and M. L. Fernandez Cardioprotective Effects of Dietary Polyphenols J. Nutr., October 1, 2005; 135(10): 2291 - 2294. [Abstract] [Full Text] [PDF]

				T. L. Zern, R. J. Wood, C. Greene, K. L. West, Y. Liu, D. Aggarwal, N. S. Shachter, and M. L. Fernandez Grape Polyphenols Exert a Cardioprotective Effect in Pre- and Postmenopausal Women by Lowering Plasma Lipids and Reducing Oxidative Stress J. Nutr., August 1, 2005; 135(8): 1911 - 1917. [Abstract] [Full Text] [PDF]

				E. M. Allister, N. M. Borradaile, J. Y. Edwards, and M. W. Huff Inhibition of Microsomal Triglyceride Transfer Protein Expression and Apolipoprotein B100 Secretion by the Citrus Flavonoid Naringenin and by Insulin Involves Activation of the Mitogen-Activated Protein Kinase Pathway in Hepatocytes Diabetes, June 1, 2005; 54(6): 1676 - 1683. [Abstract] [Full Text] [PDF]

				J. J. Liang, P. Oelkers, C. Guo, P.-C. Chu, J. L. Dixon, H. N. Ginsberg, and S. L. Sturley Overexpression of Human Diacylglycerol Acyltransferase 1, Acyl-CoA:Cholesterol Acyltransferase 1, or Acyl-CoA:Cholesterol Acyltransferase 2 Stimulates Secretion of Apolipoprotein B-containing Lipoproteins in McA-RH7777 Cells J. Biol. Chem., October 22, 2004; 279(43): 44938 - 44944. [Abstract] [Full Text] [PDF]

				A. Casaschi, G. K. Maiyoh, B. K. Rubio, R. W. Li, K. Adeli, and A. G. Theriault The Chalcone Xanthohumol Inhibits Triglyceride and Apolipoprotein B Secretion in HepG2 Cells J. Nutr., June 1, 2004; 134(6): 1340 - 1346. [Abstract] [Full Text] [PDF]

				N. M. Borradaile, L. E. de Dreu, and M. W. Huff Inhibition of Net HepG2 Cell Apolipoprotein B Secretion by the Citrus Flavonoid Naringenin Involves Activation of Phosphatidylinositol 3-Kinase, Independent of Insulin Receptor Substrate-1 Phosphorylation Diabetes, October 1, 2003; 52(10): 2554 - 2561. [Abstract] [Full Text] [PDF]

				T. L. Zern, K. L. West, and M. L. Fernandez Grape Polyphenols Decrease Plasma Triglycerides and Cholesterol Accumulation in the Aorta of Ovariectomized Guinea Pigs J. Nutr., July 1, 2003; 133(7): 2268 - 2272. [Abstract] [Full Text] [PDF]

				S. Pal, N. Ho, C. Santos, P. Dubois, J. Mamo, K. Croft, and E. Allister Red Wine Polyphenolics Increase LDL Receptor Expression and Activity and Suppress the Secretion of ApoB100 from Human HepG2 Cells J. Nutr., March 1, 2003; 133(3): 700 - 706. [Abstract] [Full Text] [PDF]